CRIS :: Universidad UTE

Now showing 1 - 10 of 19

Some of the metrics are blocked by your
consent settings
Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum
(Wiley, 2011-03-16)
MARTI CARVAJAL, ARTURO JOSE
;
Gabriella Comunián-Carrasco
;
Guiomar E Peña-Martí
Scopus© Citations 16
Some of the metrics are blocked by your
consent settings
Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty
(Wiley, 2013-12-31)
Andrés M. Acevedo
;
Alexandra Gómez
;
Henry A. Becerra
;
Ana P. Ríos
;
Paula C. Zambrano
<jats:sec><jats:title>BACKGROUND</jats:title><jats:p>Although hematology and oncology research is a highly relevant and evolving field, research contributions by Latin American countries, apart from Brazil, remain unclear.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>The authors performed a bibliometric analysis through a methodical search of the Latin American abstracts presented at 4 main hematology and oncology annual scientific meetings from 2000 to 2010. Latin American regional and national productivity was described through distribution and trend analyses; the subsequent percentage of full‐text publications was also determined.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>In total, 2871 abstracts were identified, of which 1972 abstracts (68.7%) were determined to be original Latin American research and were included in the analysis. Brazil produced by far the most abstracts, with 51.1% of the total, followed by Argentina, Mexico, Peru, Chile, and Uruguay. Together, these 6 countries accounted for 95.2% of the abstracts. Latin America had a positive trend, registering an average increase of 21.5 abstracts per year (<jats:italic>P</jats:italic> < .001). Significant positive growth trends were observed for Brazil, Mexico, Peru, and Uruguay. Argentina and Uruguay were the most productive countries when considering the rate of abstract presentation per population. The full‐text publication rate was 17.9%, and the median time to publication after presentation was 1 year. Brazil prevailed as the leading publishing country (60%), followed by Mexico, Argentina, Peru, Chile, and Cuba, all of which together published 96% of the full‐text articles.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSIONS</jats:title><jats:p>Hematology and oncology research is increasing in Latin America, but this contribution remains limited to a few countries. There is also a low rate of full‐text articles derived from annual scientific meetings. More extensive research is recommended. <jats:bold><jats:italic>Cancer</jats:italic> 2014;120:1237–1245</jats:bold>. © <jats:italic>2013 American Cancer Society</jats:italic>.</jats:p></jats:sec>
Scopus© Citations 19
Some of the metrics are blocked by your
consent settings
Effectiveness of Human Recombinant Activated Protein C for Severe Sepsis and Septic Shock in Adult and Pediatric Patients
(Ovid Technologies (Wolters Kluwer Health), 2013-07)
MARTI CARVAJAL, ARTURO JOSE
;
Christian Gluud
Some of the metrics are blocked by your
consent settings
Identification of biomedical journals in Spain and Latin America
(Wiley, 2015-07-20)
Xavier Bonfill
;
Dimelza Osorio
;
Margarita Posso
;
Ivan Solà
;
Gabriel Rada
<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>Journals in languages other than English that publish original clinical research are often not well covered in the main biomedical databases and therefore often not included in systematic reviews. This study aimed to identify Spanish language biomedical journals from Spain and Latin America and to describe their main features.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Journals were identified in electronic databases, publishers' catalogues and local registries. Eligibility was determined by assessing data from these sources or the journals' websites, when available.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>A total of 2457 journals were initially identified; 1498 met inclusion criteria. Spain (27.3%), Mexico (16.0%), Argentina (15.1%) and Chile (11.9%) had the highest number of journals. Most (85.8%) are currently active; 87.8% have an <jats:styled-content style="fixed-case">ISSN</jats:styled-content>. The median and mean length of publication were 22 and 29 years, respectively. A total of 66.0% were indexed in at least one database; 3.0% had an impact factor in 2012. A total of 845 journals had websites (56.4%), of which 700 (82.8%) were searchable and 681 (80.6%) free of charge.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Most of the identified journals have no impact factor or are not indexed in any of the major databases. The list of identified biomedical journals can be a useful resource when conducting hand searching activities and identifying clinical trials that otherwise would not be retrieved.</jats:p></jats:sec>
Scopus© Citations 16
Some of the metrics are blocked by your
consent settings
Prophylactic lidocaine for myocardial infarction
(Wiley, 2015-08-21)
MARTI CARVAJAL, ARTURO JOSE
;
SIMANCAS RACINES, DANIEL ALEJANDRO
;
Vidhu Anand
;
Shrikant I Bangdiwala
Scopus© Citations 49
Some of the metrics are blocked by your
consent settings
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
(John Wiley & Sons, Ltd, 2013-01-31)
MARTI CARVAJAL, ARTURO JOSE
;
Andrés Felipe Cardona
;
Vidhu Anand
;
Ivan Solà
;
Arturo J Martí-Carvajal
Scopus© Citations 30
Some of the metrics are blocked by your
consent settings
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
(John Wiley & Sons, Ltd, 2013-02-28)
MARTI CARVAJAL, ARTURO JOSE
;
Vidhu Anand
;
Andrés Felipe Cardona
;
Ivan Solà
;
Arturo J Martí-Carvajal
Scopus© Citations 9
Some of the metrics are blocked by your
consent settings
Antibiotics for treating acute chest syndrome in people with sickle cell disease
(John Wiley & Sons, Ltd, 2013-01-31)
MARTI CARVAJAL, ARTURO JOSE
;
Lucieni O Conterno
;
Jennifer M Knight-Madden
;
Arturo J Martí-Carvajal
Scopus© Citations 15
Some of the metrics are blocked by your
consent settings
Homocysteine-lowering interventions for preventing cardiovascular events
(John Wiley & Sons, Ltd, 2013-01-31)
MARTI CARVAJAL, ARTURO JOSE
;
Ivan Solà
;
Dimitrios Lathyris
;
Despoina-Elvira Karakitsiou
;
SIMANCAS RACINES, DANIEL ALEJANDRO
Scopus© Citations 115
Some of the metrics are blocked by your
consent settings
Interventions for treating intrahepatic cholestasis in people with sickle cell disease
(Wiley, 2020-06-22)
MARTI CARVAJAL, ARTURO JOSE
;
Cristina Elena Martí-Amarista
Scopus© Citations 1

CRIS

Browse

Filters

Settings

Sort By

Results per page

Search Results